Clearmind Medicine (CMND) Enterprise Value (QoQ) (2022 - 2026)
Clearmind Medicine (CMND) Enterprise Value (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - |
| 10 | Clearmind Medicine | 544,743.06 | -13.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -31.37% |
| Jan 31, 2026 | -85.25% |
| Oct 31, 2025 | -59.75% |
| Jul 31, 2025 | 24.81% |
| Apr 30, 2025 | 21.40% |
| Jan 31, 2025 | 13.80% |
| Oct 31, 2024 | 10.72% |
| Jul 31, 2024 | 7.90% |
| Apr 30, 2024 | 10.52% |
| Jan 31, 2024 | -69.16% |
| Oct 31, 2023 | -40.18% |
| Jan 31, 2023 | -2,172.60% |
| Jan 31, 2022 | 39.53% |